These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34775392)

  • 1. Nimodipine in Clinical Practice: A Pharmacological Update.
    Clough B; Tenii J; Wee C; Gunter E; Griffin T; Aiyagari V
    J Neurosci Nurs; 2022 Feb; 54(1):19-22. PubMed ID: 34775392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
    Vázquez-Medina A; Turnbull MT; James CL; Cowart JB; Lesser E; Carter RE; Ross OA; Miller DA; Meschia JF; De Jesús Espinosa A; Weinshilboum R; Freeman WD
    Pharmacogenomics J; 2024 Jun; 24(4):19. PubMed ID: 38890281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.
    Hajizadeh Barfejani A; Rabinstein AA; Wijdicks EFM; Clark SL
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2155-2158. PubMed ID: 31103551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of Cytochrome P450 of Nimodipine Metabolism After Aneurysmal Subarachnoid Hemorrhage.
    Peacock SH; James C; Turnbull MT; Cowart JB; Reid JM; Freeman WD
    J Neurosci Nurs; 2019 Oct; 51(5):238-242. PubMed ID: 31469704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
    Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
    Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study.
    Mahmoud SH; Hefny FR; Panos NG; Delucilla L; Ngan Z; Perreault MM; Hamilton LA; Rowe AS; Buschur PL; Owusu-Guha J; Almohaish S; Sandler M; Armahizer MJ; Barra ME; Cook AM; Barthol CA; Hintze TD; Cantin A; Traeger J; Blunck JR; Shewmaker J; Burgess SV; Kaupp K; Brown CS; Clark SL; Wieruszewski ED; Tesoro EP; Ammar AA; Ammar MA; Binning MJ; Naydin S; Fox N; Peters DM; Mahmoud LN; Keegan SP; Brophy GM
    Pharmacotherapy; 2023 Apr; 43(4):279-290. PubMed ID: 36880540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage.
    Soppi V; Karamanakos PN; Koivisto T; Kurki MI; Vanninen R; Jaaskelainen JE; Rinne J
    World Neurosurg; 2012 Jul; 78(1-2):101-9. PubMed ID: 22120252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
    Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
    Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
    Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL;
    Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients.
    Cho S; Bales J; Tran TK; Korab G; Khandelwal N; Joffe AM
    Ann Pharmacother; 2016 Sep; 50(9):718-24. PubMed ID: 27273676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage.
    Mindt S; Tokhi U; Hedtke M; Groß HJ; Hänggi D
    J Clin Pharm Ther; 2020 Feb; 45(1):81-87. PubMed ID: 31421063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Modified Nimodipine Dosing in Aneurysmal Subarachnoid Hemorrhage.
    Mahmoud L; Zullo AR; Blake C; Dai X; Thompson BB; Wendell LC; Furie KL; Reznik ME; Mahta A
    World Neurosurg; 2022 Feb; 158():e501-e508. PubMed ID: 34775086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
    Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nimodipine on pulmonary function in artificially ventilated patients with aneurysmal subarachnoid hemorrhage.
    Lunkiewicz J; Brandi G; Willms J; Strässle C; Narula G; Keller E; Muroi C
    Acta Neurochir (Wien); 2021 Oct; 163(10):2715-2721. PubMed ID: 33825057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
    Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
    Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Isse FA; Abdallah YEH; Mahmoud SH
    J Pharm Pharm Sci; 2020; 23(1):100-108. PubMed ID: 32348716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxemia associated with nimodipine in a patient with an aneurysmal subarachnoid hemorrhage.
    Baker M; Bastin MT; Cook AM; Fraser J; Hessel E
    Am J Health Syst Pharm; 2015 Jan; 72(1):39-43. PubMed ID: 25511836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dangers of outpatient nimodipine use after spontaneous subarachnoid hemorrhage in accordance with the Comprehensive Stroke Center guidelines.
    Chen CJ; Turnage C; Sokolowski JD; Kumar JS; Kalani MY; Park MS
    J Clin Neurosci; 2018 Jun; 52():151-152. PubMed ID: 29656002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.
    Porchet F; Chioléro R; de Tribolet N
    Acta Neurochir (Wien); 1995; 137(1-2):62-9. PubMed ID: 8748871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.